VC

This section provides exclusive insights from Venture Capital (VC) firms, including investment trends, funding rounds, and emerging opportunities in the startup ecosystem. Understanding the VC landscape is crucial for founders looking to raise capital, navigate funding stages, and build relationships with investors.

Stay updated on the latest funding rounds, market shifts, and VC-backed success stories. Learn about investment strategies, due diligence, and what top venture firms look for in startups. This section also features interviews with investors and deep dives into funding trends across industries like AI, fintech, and healthcare.

This section is curated by:

Sofya Zhamoitina

Venture Reporter

Venture Reporter at The Top Voices | Startup ecosystem navigator | Tracking early-stage funding, sharing tech insights, and publicly supporting founders | Business Administration and International Finance student at Bahcesehir University

AI VC

February 19, 2025

2 min

Valid Secures $5.5M to Revolutionize AI-Powered Advertising

Valid, an AI-driven ad agency, raised $5.5M in a seed round led by Canaan Partners, bringing total funding to $7.3M.

AI VC

February 18, 2025

2 min

Singulr AI Secures $10M to Launch Enterprise AI Governance Platform

Singulr AI launched its AI governance platform with $10M seed funding from Nexus Venture Partners, Dell Technologies Capital, and industry leaders.

VC Software

February 18, 2025

1 min

Imperia Raises €10M to Accelerate AI-Powered Supply Chain Innovation

Imperia closed a €10M Series A, co-led by Burda Principal Investments & Samaipata, with Acurio Ventures & Draper B1 joining to fuel growth and innovation.

AI VC

February 14, 2025

2 min

Akamas Secures $10M to Expand AI-Driven Cloud Optimization in North America

Akamas secured $10M from United Ventures to expand in North America, boost product development, and optimize cloud and Kubernetes.

February 14, 2025

2 min

StemSight Secures €2.3M to Advance Stem Cell Therapy for Corneal Blindness

StemSight raised €2.3M for stem cell therapies targeting vision restoration and limbal stem cell deficiency.

Previous Next

This section is curated by:

Sofya Zhamoitina

Venture Reporter